Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 117, Issue 1, Pages 133-135Publisher
WILEY
DOI: 10.1046/j.1365-2141.2002.03407.x
Keywords
myeloma; FDG-PET; imaging; occult disease; non-secretory
Categories
Ask authors/readers for more resources
Positron emission tomography with 2-deoxy-2-[18]fluoro-d-glucose (FDG-PET) imaging has been extensively used to detect occult metastatic malignant lesions in patients with carcinoma. We describe its use in three patients with multiple myeloma, each representing a particular clinical situation in which this imaging modality offered advantages over plain radiography, computerized tomography or magnetic resonance imaging. FDG-PET provides a whole body image showing sites of occult disease. This is of particular value in patients with non-secretory myeloma, solitary plasmacytoma or for those that relapse with focal disease following autologous or allogeneic stem cell transplantation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available